Income Statement

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Revenues $ 3,391,582 $ 1,715,697 $ 8,411,858 $ 4,487,473
Cost of revenues, including depreciation 1,521,783 548,181 3,324,009 1,488,542
Gross profit 1,869,799 1,167,516 5,087,849 2,998,931
Operating expenses:        
Personnel 352,257 269,795 821,815 574,481
Marketing and promotion 37,202 29,286 166,906 144,020
General and administrative 619,419 581,391 2,140,816 1,163,718
Total operating expenses 1,008,878 880,472 3,129,535 1,882,218
Operating income 860,921 287,044 1,958,314 1,116,713
Non-operating expenses:        
Interest expense, net 454,847 89,934 1,018,460 267,840
Amortization of stock option and warrant issuances 8,109,661 274,224 14,973,270 293,519
Loss on debt settlements 2,407,671 463,855 4,184,631 482,133
Other (226,940) 3,600 (226,940)
Total non-operating expenses 10,972,179 601,073 20,179,961 816,552
Net income (loss) (10,111,258) (314,029) (18,221,647) 300,161
Net income (loss) attributable to noncontrolling interests 91,362 78,421 223,882 177,852
Net income (loss) attributable to MariMed Inc. $ (10,202,620) $ (392,450) $ (18,445,529) $ 122,309
Net income (loss) per share $ (0.052) $ (0.002) $ (0.099) $ 0.001
Weighted average common shares outstanding 196,415,503 163,737,564 186,952,362 97,982,499

Source